Cargando…
Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis
BACKGROUND: Dialysis patients are predisposed to severe disease and have a high mortality rate in coronavirus disease 2019 (COVID-19) due to their comorbidities and immunocompromised conditions. Therefore, dialysis patients should be prioritized for vaccination. This study aimed to examine how long...
Autores principales: | Yoshifuji, Ayumi, Toda, Masataro, Ryuzaki, Munekazu, Kikuchi, Kan, Kawai, Toru, Sakai, Ken, Oyama, Emi, Koinuma, Masayoshi, Katayama, Kazuhiko, Uehara, Yuki, Ohmagari, Norio, Kanno, Yoshihiko, Kon, Hirofumi, Shinoda, Toshio, Takano, Yaoko, Tanaka, Junko, Hora, Kazuhiko, Nakazawa, Yasushi, Hasegawa, Naoki, Hanafusa, Norio, Hinoshita, Fumihiko, Morikane, Keita, Wakino, Shu, Nakamoto, Hidetomo, Takemoto, Yoshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388964/ https://www.ncbi.nlm.nih.gov/pubmed/35999867 http://dx.doi.org/10.1186/s41100-022-00427-2 |
Ejemplares similares
-
T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2023) -
Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
por: Yoshifuji, Ayumi, et al.
Publicado: (2022) -
Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022) -
Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022) -
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021)